← Back to Search

AR Tool for Post-Surgery Symptoms in Pediatric Cancer Patients

N/A

Recruiting

Led By Juan Cata, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Surgery with an estimated duration longer than 2 hours

Current diagnosis of pediatric cancer or benign neoplasm

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion; an average of 1 year

Awards & highlights

Study Summary

This trial tests if a tool can measure pain, nausea, and vomiting in Hispanic kids with cancer after surgery.

Who is the study for?

This trial is for English or Spanish-speaking kids aged 7-17 with cancer who are having surgery lasting over 2 hours and will need painkillers like opioids after. They must be able to understand and use the game in the study, and have a guardian's consent. Kids can't join if their doctor thinks the app isn't right for them or if parents don't agree.Check my eligibility

What is being tested?

The study is testing how well an electronic tool works when used by kids recovering from cancer surgery to report their pain, nausea, and vomiting. It uses augmented reality (AR) technology to help measure these postoperative conditions.See study design

What are the potential side effects?

Since this trial involves using an electronic assessment tool rather than a medication, there aren't typical drug side effects. However, discomfort or frustration with using the AR tool could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My surgery is expected to last more than 2 hours.

Select...

I am currently diagnosed with cancer or a non-cancerous tumor as a child.

Select...

I can agree to participate, and my legal guardian can give informed consent for me.

Select...

I am between 7 and 17 years old.

Select...

I will be prescribed opioids after surgery while in the hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion; an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion; an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Activation and use of the technology (YES versus NO)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Augmented reality (AR)Experimental Treatment1 Intervention

Augmented reality (AR) Participants will view the real world through a device's camera and application ("app") but adds virtual or digital characters and items to the image

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,460 Total Patients Enrolled

National Institute of Drug AbuseFED

9 Previous Clinical Trials

14,503 Total Patients Enrolled

Juan Cata, MDPrincipal InvestigatorM.D. Anderson Cancer Center

5 Previous Clinical Trials

223 Total Patients Enrolled

Media Library

Augmented reality (AR) Clinical Trial Eligibility Overview. Trial Name: NCT05933252 — N/A

Cancer Research Study Groups: Augmented reality (AR)

Cancer Clinical Trial 2023: Augmented reality (AR) Highlights & Side Effects. Trial Name: NCT05933252 — N/A

Augmented reality (AR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05933252 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 80 and older being sought for participation in this investigation?

"As per the study's entrance requirements, potential participants should be within 7 to 17 years old."

Answered by AI

Do I meet the qualifications to partake in this research?

"The criteria for acceptance in this clinical trial necessitates that participants possess cancer and are between the ages of 7 and 17. A total of 16 individuals will be admitted to participate."

Answered by AI

What is the targeted enrollment size for this medical experiment?

"Affirmative. The online listing for this clinical trial, which was first made accessible on June 19th 2023, indicates that recruitment is currently active. 16 individuals are needed from 1 center of research."

Answered by AI

Is enrollment to this experiment still open?

"Yes, this trial is currently enrolling patients. The study was advertised on June 19th 2023 and recently updated on the 27th of the same month according to clinicaltrials.gov."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.

2023. "A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05933252.